CleanCap® EGFP mRNA (5moU) - (L-7201)

CleanCap®Enhanced Green Fluorescent Protein mRNA (5-methoxyuridine)
SKU Unit Size Price Qty
L-7201-100 100 µg
L-7201-1000 1 mg
L-7201-5 5 x 1 mg


The EGFP mRNA will express an enhanced version of the green fluorescent protein, originally isolated from the jellyfish, Aequorea victoria. EGFP is a commonly used direct detection reporter in mammalian cell culture, yielding bright green fluorescence with an emission peak at 509 nm.

This mRNA is capped using CleanCap, TriLink's proprietary co-transciptional capping method, which results in the naturally occuring Cap 1 structure with high capping efficiency. It is polyadenylated, modified with 5-methoxyuridine and optimized for mammalian systems. It mimics a fully processed mature mRNA.

Product Details

Catalog No L-7201
Purity Passes Agarose Gel Mobility
Length 996 nucleotides
Base Composition Fully substituted with 5-Methoxy-U
Concentration 1.0 mg/mL
Buffer 1 mM Sodium Citrate pH 6.4
Conversion Factor 40 µg/OD260
Recommended Storage At or below -40°C
Application Reporter Genes
Cap AG Start, Cap 1, CleanCap
Other Name(s) CleanCap®Enhanced Green Fluorescent Protein mRNA (5-methoxyuridine)

Certificate of Analysis

Intellectual Property

CleanCap For Research Use Only. Not for use in humans. Not for use in diagnostic or therapeutic purposes. For additional licensing restrictions, please see the license agreement at Patent or patent pending,see

Mutant GFP mRNA These products are sold with a Limited Use Label License under sublicense with Life Technologies, Inc. Please review Limited License at

Products are for research use only, not for use in diagnostic or therapeutic procedures or for use in humans. Products are not for resale without express written permission of Seller. No license under any patent or other intellectual property right of Seller or its licensors is granted or implied by the purchase unless otherwise provided in writing.

TriLink does not warrant that the use or sale of the products delivered hereunder will not infringe the claims of any United States or other patents or patents pending covering the use of the product alone or in combination with other products or in the operation of any process. All and any use of TriLink product is the purchaser's sole responsibility.


Fornaguera, Cristina; Guerra-Rebollo, Marta; Ángel Lázaro, Miguel; Castells-Sala, Cristina; Meca-Cortés, Oscar; Ramos-Pérez, Victor; Cascante, Anna; Rubio, Núria; Blanco, Jerónimo; Borrós, Salvador . mRNA Delivery System for Targeting Antigen-Presenting Cells In Vivo.

Kauffman, Amy C.; Piotrowski-Daspit, Alexandra S.; Nakazawa, Kay H.; Jiang, Yuhang; Datye, Amit; Saltzman, W. Mark . Tunability of Biodegradable Poly(amine- co-ester) Polymers for Customized Nucleic Acid Delivery and Other Biomedical Applications.

Estrada, K;Froelich, S;Wuster, A;Bauer, CR;Sterling, T;Clark, WT;Ru, Y;Trinidad, M;Nguyen, HP;Luu, AR;Wendt, DJ;Yogalingam, G;Yu, GK;LeBowitz, JH;Cardon, LR; . Identifying therapeutic drug targets using bidirectional effect genes

Grun, M;Suberi, A;Shin, K;Lee, T;Gomerdinger, V;Moscato, Z;Piotrowski-Daspit, A;Saltzman, W; . PEGylation of Poly(amine-co-ester) Polyplexes for Tunable Gene Delivery

Chi, F;Sharpley, MS;Nagaraj, R;Roy, SS;Banerjee, U; . Glycolysis-Independent Glucose Metabolism Distinguishes TE from ICM Fate during Mammalian Embryogenesis

Yang, DC;Eldredge, AC;Hickey, JC;Muradyan, H;Guan, Z; . Multivalent Peptide-functionalized Bioreducible Polymers for Cellular Delivery of Various RNAs

Tam, A;Leclair, P;Li, LV;Yang, CX;Li, X;Witzigmann, D;Kulkarni, JA;Hackett, TL;Dorscheid, DR;Singhera, GK;Hogg, JC;Cullis, PR;Sin, DD;Lim, CJ; . FAM13A as potential therapeutic target in modulating TGF-beta-induced airway tissue remodeling in COPD

Legere, RM;Cohen, ND;Poveda, C;Bray, JM;Barhoumi, R;Szule, JA;de la Concha-Bermejillo, A;Bordin, AI;Pollet, J; . Safe and effective aerosolization of in vitro transcribed mRNA to the respiratory tract epithelium of horses without a transfection agent

G . Nucleic Acid Delivery by Solid Lipid Nanoparticles Containing Switchable Lipids: Plasmid DNA vs. Messenger RNA

Munson, M;O'Driscoll, G;Silva, A;L . A high-throughput Galectin-9 imaging assay for quantifying nanoparticle uptake, endosomal escape and functional RNA delivery

Liu, K;Nilsson, R;L . An obesity model and corona multiomics analysis reveal high-density lipoprotein effects on lipid nanoparticle function

Chi, F;Sharpley, MS;Nagaraj, R;Roy, SS;Banerjee, U; . Glucose metabolism distinguishes TE from ICM fate during mammalian embryogenesis

Paramasivam, P;Stoter, M;Corradi, E;Dalla Costa, I; . Quantitative intracellular retention of delivered RNAs through optimized cell fixation and immuno-staining

Estrada, K;Froelich, S;Wuster, A;Bauer, CR;Sterling, T; . Identifying therapeutic drug targets for rare and common forms of short stature

Ulkoski, D;Munson, M;Jacobson, M;Palmer, C;Carson, C;Sabirsh, A;Wilson, J;Krishnamurthy, V; . High-Throughput Automation of Endosomolytic Polymers for mRNA Delivery

Anderson, AJ; . Design, Synthesis, and Characterization of Functional Click Nucleic Acid Polymers and Conjugates for Biological Applications

Sebastiani, F;Yanez Arteta, M;Lindfors, L;C . Screening of the binding affinity of serum proteins to lipid nanoparticles in a cell free environment

Zhang, H;Bussmann, J;Huhnke, FH;Devoldere, J;Minnaert, AK;Jiskoot, W;Serwane, F;Spatz, J;R . Together is Better: mRNA Co-Encapsulation in Lipoplexes is Required to Obtain Ratiometric Co-Delivery and Protein Expression on the Single Cell Level

Hao, S;Inamdar, VV;Sigmund, EC;Zhang, F;Stephan, SB;Watson, C;Weaver, SJ;Nielsen, UB;Stephan, MT; . BiTE secretion from in situ-programmed myeloid cells results in tumor-retained pharmacology

Rui, Y;Wilson, DR;Tzeng, SY;Yamagata, HM;Sudhakar, D;Conge, M;Berlinicke, CA;Zack, DJ;Tuesca, A;Green, JJ; . High-throughput and high-content bioassay enables tuning of polyester nanoparticles for cellular uptake, endosomal escape, and systemic in vivo delivery of mRNA

Darade, AR;Lapteva, M;Hoffmann, T;Mandler, M;Schneeberger, A;Kalia, YN; . Effect of mRNA Delivery Modality and Formulation on Cutaneous mRNA Distribution and Downstream eGFP Expression

Shi, Y;Lu, Y;Qin, B;Jiang, M;Guo, X;Li, X;Liu, Y;Huang, J;Zhang, J;Luo, Z;Yin, H;Liu, H;Guan, G;Du, Y;Peng, L;You, J; . Antigen transfer from non-APCs to APCs impacts the efficacy and safety of protein- and mRNA- based vaccines